The effectiveness of vaccination on the COVID-19 epidemic in California

被引:1
作者
Huang, Elijah [1 ]
Kurkure, Siddharth [1 ]
Seo, Yui [1 ]
Lau, Kristie [1 ]
Puglisi, Jose [1 ]
机构
[1] Calif Northstate Univ, Coll Med, Elk Grove, CA USA
关键词
Epidemiology; COVID; Vaccine; Cohort study;
D O I
10.1016/j.ajic.2024.05.020
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The COVID-19 pandemic has caused overwhelming morbidity, mortality, and hospitalization worldwide, including in the state of California. Vaccination efforts have been an important measure in curtailing the adverse outcomes of COVID-19. Methods: To quantify the effectiveness of COVID-19 vaccinations in California, we conducted a retrospective cohort study investigating how vaccination has impacted the extent of COVID-19 contraction, hospitalizations, and death totals. We compared outcomes of the Delta Wave, Omicron Wave, and Pre-Delta Period. Results: Vaccinated individuals have far-lower incidence risk ratio (IRR) of and odds of contracting a COVID-19 case (Delta IRR: 0.197) being hospitalized from COVID-19 (Delta IRR: 0.105), and dying from COVID-19 compared with an unvaccinated individual (Delta IRR: 0.0941). The preventive fraction of the unexposed and population-preventive fractions for cases, deaths, and hospitalizations also showed significant proportions. All tests showed P < .001. Discussion: Vaccination was most effective in the Delta Wave, then in the Omicron Wave, and least effective in the Pre-Delta Period. Deaths were the most prevented outcome, followed by hospitalizations, then cases. Conclusions: This study exposes the massive impact of vaccinations in California in reducing COVID-19 outcomes and the potential for fewer adverse outcomes had there been greater vaccination compliance, demonstrating the need to increase vaccination efforts. (c) 2024 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:1252 / 1257
页数:6
相关论文
共 23 条
[1]  
[Anonymous], Overview of COVID-19 vaccines
[2]  
[Anonymous], 2021, A Timeline of COVID-19 vaccine developments in 2021
[3]  
[Anonymous], Estimates-E1
[4]   Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes [J].
Buchan, Sarah A. ;
Chung, Hannah ;
Brown, Kevin A. ;
Austin, Peter C. ;
Fell, Deshayne B. ;
Gubbay, Jonathan B. ;
Nasreen, Sharifa ;
Schwartz, Kevin L. ;
Sundaram, Maria E. ;
Tadrous, Mina ;
Wilson, Kumanan ;
Wilson, Sarah E. ;
Kwong, Jeffrey C. .
JAMA NETWORK OPEN, 2022, 5 (09) :E2232760
[5]  
cdc, Coronavirus disease 2019 (covid-19): People with asthma
[6]  
cdph, California S of. Tracking COVID-19 in California
[7]   Safety & effectiveness of COVID-19 vaccines: A narrative review [J].
Chirico, Francesco ;
Teixeira da Silva, Jaime A. ;
Tsigaris, Panagiotis ;
Sharun, Khan .
INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 155 (01) :91-104
[8]  
data.chhs.ca, COVID-19 Post-Vaccination Infection Data (ARCHIVED)-Datasets-California Health and Human Services Open Data Portal
[9]   Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs OmicronWaves [J].
Doll, Margaret K. ;
Waghmare, Alpana ;
Heit, Antje ;
Shakoor, Brianna Levenson ;
Kimball, Louise E. ;
Ozbek, Nina ;
Blazevic, Rachel L. ;
Mose, Larry ;
Boonyaratanakornkit, Jim ;
Stevens-Ayers, Terry L. ;
Cornell, Kevin ;
Sheppard, Benjamin D. ;
Hampson, Emma ;
Sharmin, Faria ;
Goodwin, Benjamin ;
Dan, Jennifer M. ;
Archie, Tom ;
O'Connor, Terry ;
Heckerman, David ;
Schmitz, Frank ;
Boeckh, Michael ;
Crotty, Shane .
JAMA NETWORK OPEN, 2023, 6 (02)
[10]   Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant? [J].
Duong, Bao V. ;
Larpruenrudee, Puchanee ;
Fang, Tianxin ;
Hossain, Sheikh I. ;
Saha, Suvash C. ;
Gu, Yuantong ;
Islam, Mohammad S. .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (08)